Publication

Epidermal growth factor dampens pro-inflammatory gene expression induced by interferon-gamma in global transcriptome analysis of keratinocytes

Correction

Downloadable Content

Persistent URL
Last modified
  • 08/21/2026
Type of Material
Authors
    David C. Gibbs, Emory UniversityMyles R. McCrary, Emory UniversityCarlos S. Moreno, University of South FloridaLindsey Seldin, University of South FloridaChaoran Li, Emory UniversityNourine A.H. Kamili, Emory UniversityBrian P. Pollack, Emory University
Language
  • English
Date
  • 2025-02-10
Publisher
  • BMC
Publication Version
Copyright Statement
  • © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025, corrected publication 2025
  • © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 26
Start Page
  • 122
Grant/Funding Agency
  • United States (U.S.) Department of Veterans Affairs
  • Joseph Maxwell Cleland Atlanta VA Medical Center
Grant/Funding Information
  • This work was supported by Merit Review Award # 5I01BX001922 from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Service. BPP is currently employed by the Joseph Maxwell Cleland Atlanta VA Medical Center as the Dermatology Section Chief in the Medical Specialty Care Service line.
Supplemental Material (URL)
Abstract
  • Background Epidermal growth factor receptor inhibitors (EGFRIs) are used to treat certain cancers but frequently cause cutaneous inflammation that can hinder treatment. This is due in part to the effects of EGFRIs on pro-inflammatory signaling by interferon-γ (IFN-γ). However, the impact of EGFR ligands (i.e. EGF) on interferon signaling is unclear. The purpose of this study was to investigate the impact of EGF on IFN-γ transcriptional responses on a genome-wide scale in keratinocytes. Methods RNA-seq was performed in human keratinocyte (HaCaT) cells treated with IFN-γ, EGF, both, or neither (control). Differentially expressed genes in each treatment group, relative to control, were identified using DESeq2 with a false discovery rate (FDR) threshold of 0.01. Associated biologic processes and gene pathways were examined in gene-set enrichment analyses. Correlations between gene expression were investigated in vivo using RNA-seq data from biopsies of psoriatic and matched normal skin, which were collected from 116 individuals with psoriasis enrolled in the AMAGINE randomized clinical trials. Results Of the 2,792 differentially expressed genes following IFN-γ treatment, 2,083 (75%) were no longer differentially expressed when EGF was added. IFN-γ-induced genes with significantly lower expression in the presence of EGF included CXCL10, IL-6, IL-1 A, HLA-DMA, and GBP5 (activator of the NLRP3 inflammasome); the top enriched biologic processes and pathways were related to MHC-class II antigen presentation (GO:0019886) and cytokine signaling (KEGG:04060). Consistent with our in vitro findings, the expression of CXCL10 and GBP5, as well as the combined expression z-scores of genes in the enriched MHC-class II and cytokine signaling pathways, were significantly lower in skin biopsies with higher EGF expression compared to those with lower EGF expression among individuals with psoriasis. Conclusions Our findings suggest that the pro-inflammatory IFN-γ-induced transcriptome may be globally attenuated by EGF in keratinocytes, supporting an immunomodulatory role of EGF in the skin. These studies provide insights for the non-canonical immunomodulatory role of EGF signaling and why blocking EGFR signaling (e.g., with EGFRIs) can cause cutaneous inflammation.
Author Notes
  • We would like to thank Prachi Gupta and Gregory Tharp (Emory National Primate Research Center, Genomics Core Laboratory, Division of Microbiology & Immunology, Emory University, Atlanta, GA) and the Emory Integrated Genomics Core (EIGC) for their assistance with RNA sequencing.
  • DCG, MRM, CSM, and BPP designed the study; BPP performed the experiments; DCG, MRM, CSM, LS, CL, NAHK, and BPP interpreted the data; DCG, MRM and NAHK prepared the tables and figures; DCG and MRM drafted the manuscript; DCG, MRM, CSM, LS, CL, NAHK, and BPP edited and approved the final manuscript. All authors are accountable for their contributions and agree to the integrity of the work.
  • Institutional Review Board (IRB) approval was not required as this was non-human subjects research. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.
  • Following publication of the original article, it was reported that there was an error in the affiliation assignment in the authorship panel.
Keywords
Research Categories
  • Immunology
  • Oncology

Tools

Relations

In Collection: